Minias

Savona, Italy Founded: 2015 • Age: 11 yrs Acquired By KPM Analytics
Research instruments and supplies are provided via an online platform.

About Minias

Minias is a Healthcare company based in Savona (Italy) founded in 2015, and was acquired by KPM Analytics in April 2011. It operates as a research instruments and supplies are provided via an online platform. Minias offers products and services including Veri-Q MULTI COLESTEROLO TOTALE, Veri-Q MULTI, Veri-Q MULTI PROFILO LIPIDICO, Veri-Q MULTI GLUCOSIO, and Veri-Q MULTI EMOGLOBINA. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Scientific Sourcing. Its legal entity is Minias Globe Diagnostics SRL. Its competitors include PerkinElmer, Cytiva, Labviva, Zageno and Fortis Life Sciences and 4 more; 3 of its 9 listed competitors have raised funding.

Company details

Minias was founded in 2015 in Savona, Italy, within the scientific research sector. An online platform is operated by the company, through which a range of research instruments, supplies, immuno-diagnostic kits, and reagents are supplied to users. Operations focus on facilitating access to these materials for diagnostic and experimental purposes, with services extending across Italy via the domain minias.it.

  • Headquarters Savona, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Website minias.it
  • Acquired by KPM Analytics (Apr 2011)
  • Legal Name Minias Globe Diagnostics Srl
Key Metrics

Products & Services of Minias

Minias offers a comprehensive portfolio of products and services, including Veri-Q MULTI COLESTEROLO TOTALE, Veri-Q MULTI, Veri-Q MULTI PROFILO LIPIDICO, Veri-Q MULTI GLUCOSIO, and Veri-Q MULTI EMOGLOBINA.

Veri-Q MULTI COLESTEROLO TOTALE
Diagnostic Kit

Kit for testing total cholesterol levels in blood.

Veri-Q MULTI
Diagnostic Kit

Multi-functional device for various health profiles.

Veri-Q MULTI PROFILO LIPIDICO
Diagnostic Kit

Test kit for lipid profile analysis.

Veri-Q MULTI GLUCOSIO
Diagnostic Kit

Kit to measure glucose levels in blood.

Veri-Q MULTI EMOGLOBINA
Diagnostic Kit

Device for hemoglobin testing.

LAB Anti A
Diagnostic Kit

Antibody test for blood typing.

Investors in Minias

Minias has secured backing from 1 investor. Prominent investors backing the company include KPM Analytics.

All
InvestorDescriptionFounded YearDomainLocation
Provider of analytical instrumentation and solutions for food, agricultural, and industrial quality control
2015kpmanalytics.comBoston, United States
Premium access

Investor details for Minias

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Minias

2 dated milestones of Minias across 4 years, from founding to its latest funding, stage changes and deals.

  1. Exit Acquired by KPM Analytics.
  2. Founded Minias is founded.

Competitors of Minias

Minias has 9 listed competitors in our database, 3 of them funded. They include PerkinElmer, Cytiva, Labviva, Zageno and Fortis Life Sciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
perkinelmer.com1931Waltham, United States–219
Medical instruments and supplies are manufactured and provided for healthcare.
cytivalifesciences.com1968Sheffield, United Kingdom–578
Life science software and research products are provided online.
labviva.com2017Cambridge, United States$55.75M8
An AI-powered marketplace for life science products is operated.
zageno.com2015Cambridge, United States$120.93M51
Marketplace and life science research community for biotech research kits
fortislife.com2020Waltham, United States––
A trusted partner in life sciences and diagnostics solutions.
leicabiosystems.com1989Nussloch, Germany–365
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
geneseesci.com1995El Cajon, United States–74
Life science research products are sold via an online store.
meenta.io2016Boston, United States$2.47M–
Operates a digital marketplace for sequencing instruments.
celltreat.com2008Pepperell, United States––
Produces laboratory plastic consumables like pipets and vials for efficient scientific research.
Premium access

Detailed competitors of Minias

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Minias

The website of Minias (minias.it) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▼ 25.4% vs previous month

Top companies in Life Sciences Platforms & Tools

10 companies that operate in the same segment as Minias (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Minias

Minias was founded in 2015.

Minias is headquartered in Savona, Italy. It is registered at Savona, Liguria, Italy.

Minias was founded in 2015 in Savona, Italy, within the scientific research sector. An online platform is operated by the company, through which a range of research instruments, supplies, immuno-diagnostic kits, and reagents are supplied to users. Operations focus on facilitating access to these materials for diagnostic and experimental purposes, with services extending across Italy via the domain minias.it.

Minias's top competitors include Labviva, Cytiva and Zageno.

Minias offers Veri-Q MULTI COLESTEROLO TOTALE, Veri-Q MULTI, Veri-Q MULTI PROFILO LIPIDICO, Veri-Q MULTI GLUCOSIO, and 2 more products and services.

Minias has 1 investor. Key investors include KPM Analytics.

Minias operates through Minias Globe Diagnostics Srl.

Yes. Minias was acquired by KPM Analytics in April 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available